−137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease

References

• Schreiber S, Hanpe J, Nikolaus S, Foelsch UR. Review article: Exploration of the genetic aetiology of inflammatory bowel disease – implications for diagnosis and therapy. Aliment Pharmacol Ther 2004; 20: S1–8
   PubMedGoogle Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925–8
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86–91
   PubMed Web of Science ®Google Scholar
• Karban A, Eliakim R. Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population. Gastroenterology 2004; 126: 624–5
   PubMedGoogle Scholar
• Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423–74
   PubMed Web of Science ®Google Scholar
• Kanai T, Watanabe M, Okazawa A, Sato T, Yamazaki M, Okamoto S, et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001; 121: 875–88
   PubMed Web of Science ®Google Scholar
• Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF, Jr, Foley E, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829–35
   PubMed Web of Science ®Google Scholar
• Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol 1999; 163: 143–7
   PubMed Web of Science ®Google Scholar
• Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 2001; 281: 1264–73
   PubMed Web of Science ®Google Scholar
• Sivakumar PV, Westrich GM, Kanaly S, Garka K, Born TL, Derry JM, et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 2002; 50: 812–20
   PubMed Web of Science ®Google Scholar
• Ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, Graber P, et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology 2001; 121: 1372–9
   PubMed Web of Science ®Google Scholar
• Stassen NA, Breit CM, Norfleet LA, Polk HC, Jr. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 2003; 134: 351–6
   PubMedGoogle Scholar
• Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51: 3347–9
   PubMed Web of Science ®Google Scholar
• Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004; 22: 73–8
   PubMed Web of Science ®Google Scholar
• Higa S, Hirano T, Mayumi M, Hiraoka M, Ohshima Y, Nambu M, et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy 2003; 33: 1097–102
   PubMed Web of Science ®Google Scholar
• Kruse S, Kuehr J, Moseler M, Kopp MV, Kurz T, Deichmann KA, et al. Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 117–22
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T, et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002; 3: 394–9
   PubMed Web of Science ®Google Scholar
• Takada T, Suzuki E, Morohashi K, Gejyo F. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002; 60: 36–42
   PubMedGoogle Scholar
• Heninger E, Treszl A, Kocsis I, Derfalvi B, Tulassay T, Vasarhelyi B. Genetic variants of the interleukin-18 promoter region (−607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 2002; 16: 410–1
   Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325: 928–37
   PubMed Web of Science ®Google Scholar
• Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9: 341–2
   PubMed Web of Science ®Google Scholar
• Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, et al. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics 2001; 17: 654–5
   PubMed Web of Science ®Google Scholar
• Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–16
   PubMed Web of Science ®Google Scholar
• S.A.G.E., Statistical Analysis for Genetic Epidemiology. Computer program package available from. Statistical Solutions Ltd., CorkIreland; 2002.
   Google Scholar
• Kalina U, Ballas K, Koyama N, Kauschat D, Miething C, Arnemann J, et al. Genomic organization and regulation of the human interleukin-18 gene. Scand J Immunol 2000; 52: 525–30
   PubMed Web of Science ®Google Scholar
• Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–52
   PubMed Web of Science ®Google Scholar
• Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000; 119: 1514–23
   PubMed Web of Science ®Google Scholar
• Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, Kosaka T, et al. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 2002; 37: 111–16
   PubMed Web of Science ®Google Scholar
• Gonzalez S, Rodrigo L, Martinez-Borra J, Lopez-Vazquez A, Fuentes D, Nino P, et al. TNF-alpha −308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003; 98: 1101–6
   PubMed Web of Science ®Google Scholar
• Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999; 117: 1062–8
   PubMed Web of Science ®Google Scholar
• Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 1020–7
   PubMed Web of Science ®Google Scholar
• Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, et al. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 2001; 48: 461–7
   PubMed Web of Science ®Google Scholar
• Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637–42
   PubMed Web of Science ®Google Scholar
• Tountas NA, Casini-Raggi V, Yang H, Di Giovine FS, Vecchi M, Kam L, et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117: 806–13
   PubMed Web of Science ®Google Scholar
• Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, et al. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 1164–9
   PubMed Web of Science ®Google Scholar
• Hacker UT, Bidlingmaier C, Gomolka M, Keller E, Eigler A, Hartmann G, et al. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest 1998; 28: 214–19
   PubMedGoogle Scholar
• Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998; 43: 33–9
   PubMed Web of Science ®Google Scholar
• Craggs A, West S, Curtis A, Welfare M, Hudson M, Donaldson P, et al. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England. Scand J Gastroenterol 2001; 36: 1173–8
   PubMed Web of Science ®Google Scholar
• Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, et al. A polymorphism in the IL11 gene is associated with ulcerative colitis. Genes Immun 2002; 3: 494–6
   PubMed Web of Science ®Google Scholar
• Glas J, Torok HP, Unterhuber H, Radlmayr M, Folwaczny C. The −295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin Immunol 2003; 106: 197–200
   PubMedGoogle Scholar